NEW YORK (GenomeWeb) – A kit for detection of dengue virus manufactured by California-based Globavir Biosciences has been approved by the ministry of health and welfare in India, and the company has partnered with Suyog Diagnostics to distribute the test there.

Globavir said its test, called the PanGlob Dengue rRT-PCR kit, has higher sensitivity than other commercially available tests, allowing for detection of the virus up to five days after initial infection, when viral load is substantially decreased. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.

Mar
08
Sponsored by
Swift Biosciences

This webinar will discuss an optimized protocol for methyl-CpG binding domain sequencing (MBD-seq), which enables comprehensive, adequately powered, and cost-effective large-scale methylome-wide association studies (MWAS) of almost all 28 million CpG sites in the genome.

Apr
05
Sponsored by
Labcyte

This webinar will discuss how acoustic liquid handling can reduce the time and costs for labs performing carrier screening with next-generation sequencing.